Arunabio

Developer of a neural exosome platform to design therapeutics for the treatment of neurodegenerative diseases

placeAthens, Georgia, United States calendar_todayFounded 2003 groups40 employees language arunabio.com

Registered entities

Investor mix

8 investors on record; lead investors include Eshelman Ventures.

Investor typeCountShare
Venture capital338%
Private equity113%
Angel & family office113%
Accelerator & incubator113%
Other / undisclosed225%
Coming soon